Maryland Attorney General Anthony G. Brown reported that his Opioids Enforcement Unit has finalized settlements with Teva, Allergan, Walmart, and Walgreens, after multi-year investigations of these opioids-makers’ or chain pharmacies’ involvement in the opioid crisis in the state. The settlements …
AbbVie Inc.’s Allergan unit has reached an agreement to pay more than $2 billion to resolve thousands of lawsuits filed by state and local governments over the marketing of its Kadian opioid painkiller, according to people familiar with the matter. …
Opioid makers Allergan and Teva have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit brought by San Francisco alleging the drug industry fueled an overdose and addiction surge that created a public …
Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets, citing concerns over a rare form of cancer, after the U.S. health agency asked the drugmaker to pull the products. The Food …
The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc’s unorthodox bid to shield patents from a federal administrative court’s review by transferring them to a Native American tribe. The justices left in place a lower court ruling …
Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices of their medicines in January, ending a self-declared halt to increases made by a pharma industry under pressure from the Trump …
Allergan Plc on Thursday sued Pfizer Inc. to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought. …
U.S. judge has determined that a lawsuit the state of Oklahoma filed against the makers of opioids does not “necessarily rise” to a federal issue. The ruling by U.S. District Judge Vicki Miles-LaGrange in Oklahoma City sends the matter back …
The city of Indianapolis sued several manufacturers and distributors of prescription painkillers in federal court on Nov. 14, alleging that their actions are to blame for the city’s growing opioid crisis. The lawsuit contends that the “dramatic increase” in painkiller …
Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent – but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday …
